Trial intelligence / Profile preview

PVP Eye Drops in Soft Contact Lens Wearers

jRCT1031230239Recruiting

Start
May 2023
Modality
Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Countries
1
01

Overview

Open-label, single-arm trial of povidone in Contact lens discomfort (CLD), sponsored by none. Primary endpoints: Tear meniscus height and Non-invasive tear break-up time (NITBUT). Started May 2023; status: recruiting.

02

Drugs

povidone
03

Conditions

Contact lens discomfort (CLD)

Beyond the preview

Go deeper on jRCT1031230239.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT1031230239.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call